# OnCo record paper-storm-adjuvant-sorafenib-bruix-lancet-oncol-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-storm-adjuvant-sorafenib-bruix-lancet-oncol-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-storm-adjuvant-sorafenib-bruix-lancet-oncol-2015" ;
  schema:name "STORM: adjuvant sorafenib after resection or ablation of hepatocellular carcinoma"@en ;
  schema:description "Four years of sorafenib after curative surgery or ablation for liver cancer did not delay recurrence or lengthen survival, and caused substantial toxicity, closing the door on kinase inhibitors as adjuvant therapy."@en ;
  schema:url <https://onco.cc/key-papers/paper-storm-adjuvant-sorafenib-bruix-lancet-oncol-2015/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(15)00198-9>, <https://pubmed.ncbi.nlm.nih.gov/26361969/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(15)00198-9> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Bruix J, Takayama T, Mazzaferro V, et al." ;
  onco:cancers <https://onco.cc/cancers/hcc-early/> ;
  onco:drugs <https://onco.cc/drugs/sorafenib/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .